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Abstract
Background: Erdheim-Chester disease (ECD) is a rare multisystem non-Langerhans cell histiocytosis that is
characterized histologically by xanthogranulomatous infiltrates and radiologically by symmetrical sclerosis of long
bones. The xanthomatous process is characterized by prominent foamy histiocytes staining positive for CD68,
occasionally for PS100 and negative for S100 and CD1a. Gastroenterological involvement is exceedingly rare.
Case Presentation: This case report describes the case of a 69-year-old man who presented otherwise well to the
gastroenterology department with unspecific abdominal symptoms, nausea, vomiting and weight loss. ECD
involving the gastrointestinal tract was confirmed clinically, radiologically and histologically.
Conclusion: Gastroenterological manifestation of ECD is rare but should be considered in the differential diagnosis
in patients presenting with evidence of multi-organ disease and typical radiological features of Erdheim-Chester
disease elsewhere.
Background
Erdheim-Chester Disease (ECD) is a rare multisystem
histiocytosis characterized by the xanthomatous or
xanthogranulomatous infiltration of tissues with histio-
cytes, surrounded by fibrosis. The disease can affect
multiple organs systems, but gastrointestinal involve-
ment, is exceedingly rare. We describe here the case of
a 69-year old man with ECD who presented to the gas-
troenterology department with unspecific abdominal
symptoms, nausea, vomiting and weight loss.
Case presentation
A previously fit and well 69-year-old man was admitted
to the gastroenterology department with a short one
month history of lethargy, decreased appetite, persistent
vomiting, significant weight loss of six kilograms over 1
month and a dry cough. He denied abdominal pain, hae-
matemesis, dysphagia and a change in bowel habit and
described no cardiac, respiratory, neurological symptoms
or bone pain. His past medical history includes appen-
dectomy and total hip joint replacement. At the time of
admission, he was not on any regular medication.
Physical examination revealed that he was febrile (38.8C
°) and appeared cachexic but with no peripheral stigmata
of chronic liver disease. His abdominal examination
revealed hepatomegaly but no other organomegaly, per
rectal examination was unremarkable. His cardiopulmon-
ary examinations were unremarkable apart from bilateral
pitting edema up to his ankles. Peripheral blood analysis
revealed an anaemia of chronic disease with hemoglobin
of 108 g/L (norm - male 130 - 175 g/L), serum iron
2 μmol/L (norm 10 - 30 μmol/L), transferrin 1.4 g/L (2 -
3.5 g/L), transferrin saturation 6% (norm 16 - 50%) and
ferritin 354 μg/L (norm 20 - 500 μg/L). Consistent with a
systemic illness the c-reactive protein was increased to 208
mg/L (norm < 5 mg/L) but multiple urine and blood cul-
tures were negative for bacterial infection. Normal serum
electrolytes and creatinine of 83 μmol/L (norm 50 -
120 μmol/L). Liver function test was normal apart from a
marked hypoalbuminaemia of 28 g/L (norm 35 - 50 g/L).
Protein electrophoresis, Vitamin B12, folate, and thyroid
functions were normal. Chest X-ray showed interstitial
infiltration involving both lung bases. Lung function test
was consistent with a restrictive lung disease (FVC 3.33 L
(73%), FEV1 2.49 L (72%), FEV1/FVC 75% and decreased
in diffusion capacity (DLCO 17.81 ml/min/mmHg). Ultra-
sound of the abdomen confirmed a 19 cm hepatomegaly,
with normal liver texture and no evidence of a mass lesion.
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was performed with no significant pathology. Computer
tomography (CT) of the chest showed peri-aortic tissue
infiltration creating the appearance of “coated aorta”
(Figure 1) as well as thickening of the interlobular septa in
both lungs (Figure 2). The infiltration processes also
involved the pulmonary vessels, pericardium, lung par-
enchyma and the oesophagus. CT of the abdomen showed
hypo-attenuated homogenous tissue infiltration with weak
contrast enhancement in the renal fossa. Symmetric and
bilateral infiltration of the peri-renal, anterior and poster-
ior para-renal spaces gave the appearance of “hairy kidney”
(Figure 3). Inferior vena cava, aorta and mesentery were
also involved. These findings were seen as consistent with
a possible diagnosis of Erdheim-Chester Disease (ECD)
[1-3].
A CT guided biopsy of the retroperitoneal space and a
bone marrow aspiration were performed which were
inconclusive, consistent with reactive inflammatory pro-
cesses. To confirm the diagnosis of ECD a laparotomy
was performed to obtain tissue for diagnostic purposes.
Operative findings revealed an infiltrating process invol-
ving the liver, omentum and small bowel mesentery.
Biopsies were taken from the liver (Figure 4), the omen-
tum (Figure 5) and mesenteric lymph nodes (Figure 6).
Histological examination of the tissue showed xantho-
matous infiltration involving the liver, omentum and
surrounding the lymph nodes. The xanthomatous pro-
cess was characterized by prominent foamy histiocytes,
admixed with occasional giant cells and chronic inflam-
matory cells. Immunohistochemical stains revealed that
these cells were positive for CD68 and negative for S100
and CD1a. There was no evidence of malignancy and
the findings allowed a diagnosis of severe multi-organ
ECD [1].
Subsequent magnetic resonance imaging (MRI)
(Figure 7) of the whole body showed an increased mar-
row signal in the distal femur and proximal tibia consis-
tent with ECD [4]. Due to further rapid decline, the
patient was started on total parenteral nutrition, IV
hydrocortisone at 1 g once daily for 2 days, then 500
mg once daily for 8 days before changing to oral predni-
sone at 100 mg (1 mg/kg/day) for a week. The predni-
sone dose was then tapered down to 30 mg once daily.
Although the patient’s appetite improved after the initia-
tion of steroid treatment, hypoalbuminaemia persisted
and thrombocytopenia developed. One month after
initiation of treatment the patient died of respiratory
failure.
Figure 1 Axial view of the chest shows presence of peri-aortic
and oesophageal infiltration.
Figure 2 Imaging of the lung with interstitial thickening of the
interlobular septa.
Figure 3 Axial view shows bilateral and symmetric peri-renal
infiltration. Irregular bands present along posterior parts of peri-
renal infiltration gives the appearance of “hairy kidney”. The
posterior margin of the pancreas is indistinct due to the infiltrate in
the retroperitoneum.
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Erdheim-Chester Disease (ECD) is a rare multisystem
non-Langerhans cell histiocytosis first described by
Jakob Erdheim and William Chester in 1930 [5] and
since then approximately 400 cases have been reported
[6]. It is characterized by the xanthomatous or xantho-
granulomatous infiltration of tissues with foamy histio-
cytes, surrounded by fibrosis. The aetiology of the
disease remains unknown. The disease can affect multi-
ple organs systems, including musculoskeletal, central
nervous, cardiac, pulmonary and renal systems. Gastro-
intestinal involvement, despite being seen more often in
other histiocytoses [7], is exceedingly rare and to our
knowledge there are 2 case reports regarding involve-
ment of the liver and biliary system [4,8].
Two criteria, of which one should be fulfilled, were pro-
posed by Veyssier-Belot [1] in 1996 as a requirement for
the diagnosis of ECD. (1) Typical histological findings with
foamy histiocytes nested among polymorphic granuloma
and fibrosis or xanthogranulomatosis with CD68-positive
and CD1a-negative immunohistochemical staining. (2)
Typical skeletal findings with a) radiographs showing bilat-
eral and symmetric osteosclerosis of the diaphyseal and
metaphyseal regions in the bones and/or b) symmetric
and abnormally increased labeling of the distal ends of the
long bones of the lower limbs, and sometimes the upper
limbs, on 99Tc bone scintigraphies.
There are typical radiological and pathological features
which can lead to the diagnosis, but the clinical spectrum
shows a broad variation, ranging from asymptomatic tis-
sue infiltration to fulminant multisystem organ failure.
Bone pain is the most common presenting symptom
of ECD mainly affecting the legs, especially knees and
Figure 5 Biopsy of omentum showed histiocytic infiltrate.
Figure 6 Biopsy of mesenteric lymph nodes showed evidence
of perinodal histiocytic infiltrate.
Figure 7 MRI scan showed an increased marrow signal in the
distal femur and proximal tibia.
Figure 4 Histology of the liver showed a predominantly
histiocytic (foamy histiocytes) infiltrate.
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with ECD [1,9-12]. About half of all patients have extra-
skeletal manifestations including retroperitoneal fibrosis,
orbital infiltration, interstitial lung disease [2,13], bilat-
eral adrenal involvement [14], testis infiltration [15],
breast, central nervous [9,16,17] and/or cardiovascular
system [18]. Other general symptoms such as fever,
weight loss and weakness can also occur.
Retroperitoneal involvement is secondary to infiltra-
tion of the fat and surrounding structures by histiocytes
and associated fibrosis. This process can lead to peri-
renal and/or ureteral obstruction causing renal impair-
ment. This is reported to occur in 29-59% of patients
with ECD [1,19]. Erdheim-Chester infiltration is distin-
guished from retroperitoneal fibrosis principally by its
many foamy histiocytes, lack of plasma cells, and lack of
vasculitis [20].
The cardiovascular manifestations of ECD have been
known to exist since the disease was first described; this
occurs in about 40% of the patients with peri-aortic “fibro-
sis” as the most frequent cardiovascular involvement.
Other manifestations include heart failure, valvular dys-
function, reno-vascular hypertension and pericarditis [18].
It was previously thought that only about 20% of patients
have lung involvement however, a recent study reported
clinical and/or radiological pulmonary involvement in up
to 59% of patients [2]. Usually patients present with dys-
pnea or a dry cough [2]. Most patients have mediastinal
infiltration, diffuse interstitial infiltrates and pleural and/or
interlobar septal thickening best seen on high-resolution
CT [3]. Characteristic lung histopathology includes the
accumulation of histiocytes with variable amounts of fibro-
sis and a variable lymphoplasmacytic infiltrate in a lym-
phangitic distribution [13].
The involvement of liver, pancreas, mesentery and
gastrointestinal tract is extremely rare [8,4]. The diagno-
sis of ECD in our patient was challenging as he pre-
sented with unspecific symptoms such as a decrease in
appetite, persistent vomiting, weight loss and fever. He
had features of malnutrition with cachexia, peripheral
oedema secondary to hypoalbuminaemia. Evidence of
both hepatic and mesenteric involvement of ECD was
present, with operative findings of liver, omentum and
small bowel mesentery infiltration. Liver biopsy showed
xanthomatous infiltration with prominent foamy histio-
cytes positive for CD68 and negative for S100 and
CD1a. Biopsies also confirmed the involvement of
mesenteric lymph nodes and the omentum. It was inter-
esting to see that a normal liver function test does not
preclude the involvement of the liver by histiocytic infil-
tration in ECD. Our patient also showed features consis-
tent with skeletal involvement with MRI demonstrating
increased marrow signal in the distal femur and proxi-
mal tibia. Although bone pain is the most common
presenting of ECD, he remained asymptomatic from his
skeletal lesions. Other features of ECD demonstrated in
our patient include retroperitoneal, cardiovascular and
respiratory involvement.
Various therapies for ECD have been proposed,
including corticosteroids [1], multiple chemotherapeutic
regimes including vinblastine, vincristine, cyclospho-
sphamide, doxorubicin [1], cladribine [1,21-23], radio-
therapy [19,24], cyclosporine and alpha interferon [1].
The latter treatment has gained some attention recently
with the initial report of a durable response in three
patients [25]. This was followed by a series report of
treatment with interferon-alpha in eight patients with
variable response. While treatment with interferon-alpha
is promising, mechanisms of action are still largely
unkown [26]. Prognosis of the disease depends largely
on the extent and distribution of the extra-skeletal, in
particular cardio-vascular [26] and central nervous sys-
tem [6] involvement. Based on these results it was sug-
gested by the authors that interferon-alpha is considered
as a first-line treatment for patients with ECD but a
40% mortality in the first 40 months after diagnosis has
still to be accepted [26].
In summary, we describe the case of a 69-year-old man
who presented to the gastroenterological department
with unspecific symptoms of fever, fatigue, decreased
appetite, persistent vomiting and weight loss. He had
clinical, radiological and histological features consistent
with gastrointestinal involvement of ECD. He also
demonstrated the involvement of skeletal, retroperito-
neal, cardiovascular, and respiratory system. He fulfilled
the two criteria proposed by Veyssier-Belot
1 in 1996 for
the diagnosis of Erdheim-Chester disease. Although a
bone scan was not performed, the MRI STIR showed an
increased marrow signal in the distal femur and proximal
tibia. Even though bone pain is the most commonly pre-
senting symptom in ECD, apart from general unspecific
symptoms, our patient did not show any evidence of
bone pain. Despite the multiple extra-skeletal manifesta-
tions seen radiologically, gastroenterological manifesta-
tion of ECD is rare but should be considered in the
differential diagnosis in patients presenting with evidence
of multi-organ disease and typical radiological features of
Erdheim-Chester disease elsewhere.
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